TNFSF10 and cancer: Although a variety of normal and cancer cells express DR4 and DR5, and TRAIL has been shown to activate apoptosis signaling in cancer cells, it is likely that elevated levels of DR4 and/or DR5 could sensitize cancer cells to apoptosis by chemotherapy alone or in combination with DR agonists.